These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11761944)

  • 21. [Surgical therapy of malignant liver tumors: resection and transplantation].
    Weimann A; Raab R; Pichlmayr R
    Internist (Berl); 1997 Oct; 38(10):963-9. PubMed ID: 9432504
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A resected case of combined hepatocellular carcinoma and cholangiocarcinoma associated with cystic formation.
    Utsunomiya T; Saitsu H; Saku M; Takeshita M; Yoshida K; Kajiyama K; Sugimachi K
    Hepatogastroenterology; 2000; 47(33):851-4. PubMed ID: 10919046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A case of hepatocellular-cholangiocarcinoma invading the gallbladder].
    Namkoong KY; Kang MJ; Im HM; Kim MS; Ko BS; Ahn HT; Lee JR; Kim JO
    Korean J Hepatol; 2004 Jun; 10(2):148-53. PubMed ID: 15218349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma.
    Zuo HQ; Yan LN; Zeng Y; Yang JY; Luo HZ; Liu JW; Zhou LX
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):161-5. PubMed ID: 17374575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protocol for the examination of specimens from patients with hepatocellular carcinoma and cholangiocarcinoma, including intrahepatic bile ducts. Cancer Committee of the College of American Pathologists.
    Ruby SG
    Arch Pathol Lab Med; 2000 Jan; 124(1):41-5. PubMed ID: 10629130
    [No Abstract]   [Full Text] [Related]  

  • 27. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
    Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
    J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synchronous hepatocellular carcinoma and cholangiocarcinoma arising in two different dysplastic nodules.
    Kwon Y; Lee SK; Kim JS; Ro JY; Yu E
    Mod Pathol; 2002 Oct; 15(10):1096-101. PubMed ID: 12379757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Caudate hepatectomy for cancer: a single institution experience with 150 patients.
    Hawkins WG; DeMatteo RP; Cohen MS; Jarnagin WR; Fong Y; D'Angelica M; Gonen M; Blumgart LH
    J Am Coll Surg; 2005 Mar; 200(3):345-52. PubMed ID: 15737844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
    Allam N; Khalaf H; Fagih M; Al-Sebayel M
    Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognosis of 84 intrahepatic cholangiocarcinoma patients].
    Li FH; Chen XQ; Luo HY; Li YH; Wang F; Qiu MZ; Teng KY; Li ZH; Xu RH
    Ai Zheng; 2009 May; 28(5):528-32. PubMed ID: 19624884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleolar organizer regions in cirrhosis and hepatocellular carcinoma.
    Jain R; Malhotra V; Kumar N; Sarin SK
    Trop Gastroenterol; 1998; 19(3):100-1. PubMed ID: 9828706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic recurrence of cholangiolocellular carcinoma: report of a case.
    Yamamoto M; Takasaki K; Nakano M; Saito A
    Hepatogastroenterology; 1996; 43(10):1046-50. PubMed ID: 8884337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
    Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
    Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case report combined hepatocellular and cholangiocarcinoma with sarcomatous transformation.
    Boonsakan P; Thangnapakorn O; Tapaneeyakorn J; Kositchaiwat S; Bunyaratvej S
    J Med Assoc Thai; 2007 Mar; 90(3):574-80. PubMed ID: 17427538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Isolated tumor cells in primary malignant liver tumors].
    Tannapfel A; Geissler F; Witzigmann H; Wittekind C
    Zentralbl Chir; 2000; 125(7):602-5. PubMed ID: 10960969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Surgical margin status in hepatectomy for liver tumors].
    Salloum C; Castaing D
    Bull Cancer; 2008 Dec; 95(12):1183-91. PubMed ID: 19091652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histopathology of liver cancers.
    Kojiro M
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):39-62. PubMed ID: 15757804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.